CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE: institutional ownership and insider trading
242 funds reported holding $894M of CLOVER HEALTH INVESTMENTS, CORP. /DE in their latest 13F filings; in Q2 2026 funds net bought $132M, with 42 new positions and 25 funds selling out; over the last 12 months insiders bought $0 and sold $8.82M on the open market.
Famous investors holding CLOV
- Renaissance Technologies (Renaissance Technologies): $14.7M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $22.9M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $10.3M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $5.81M, 0.0% of the portfolio
Largest institutional holders of CLOV
- BlackRock, Inc. (BLK) — $184M
- VANGUARD CAPITAL MANAGEMENT LLC — $94.5M
- GEODE CAPITAL MANAGEMENT, LLC — $56.8M
- VANGUARD GROUP INC — $55.2M
- STATE STREET CORP (STT, STT-PG) — $53.3M
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $48.2M
- Nuveen, LLC — $33.0M
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC — $28.9M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $23.4M
- CITADEL ADVISORS LLC — $22.9M
Recent CLOV insider trades
- Oct 20, 2026: Soares Karen sold 19,275 shares ($89.8K)
- Oct 19, 2026: Reynoso Jamie L. sold 4,066 shares ($17.9K)
- Oct 15, 2026: Reynoso Jamie L. sold 18,273 shares ($85.5K)
- Oct 15, 2026: Wai Conrad sold 23,627 shares ($111K)
5%+ owners
- BlackRock, Inc.: 7.2% (Schedule 13G, filed Jul 17, 2025)